HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 24-SEP-12 4H95 TITLE CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- TITLE 2 ETHYL-5-{3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- TITLE 3 YL}PYRIMIDINE-2,4-DIAMINE (UCP1006) COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.5.1.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANDIDA ALBICANS; SOURCE 3 ORGANISM_COMMON: YEAST; SOURCE 4 ORGANISM_TAXID: 5476; SOURCE 5 GENE: DFR1, DHFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET41 KEYWDS ANTIFUNGAL AGENTS, CANDIDA ALBICANS, DRUG DESIGN, ENZYME INHIBITORS, KEYWDS 2 FUNGAL PROTEINS, TETRAHYDROFOLATE DEHYDROGENASE, OXIDOREDUCTASE- KEYWDS 3 OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.L.PAULSEN,A.C.ANDERSON REVDAT 2 20-NOV-13 4H95 1 HET HETATM HETNAM REMARK REVDAT 2 2 1 SITE REVDAT 1 27-MAR-13 4H95 0 JRNL AUTH J.L.PAULSEN,K.VISWANATHAN,D.L.WRIGHT,A.C.ANDERSON JRNL TITL STRUCTURAL ANALYSIS OF THE ACTIVE SITES OF DIHYDROFOLATE JRNL TITL 2 REDUCTASE FROM TWO SPECIES OF CANDIDA UNCOVERS JRNL TITL 3 LIGAND-INDUCED CONFORMATIONAL CHANGES SHARED AMONG SPECIES. JRNL REF BIOORG.MED.CHEM.LETT. V. 23 1279 2013 JRNL REFN ISSN 0960-894X JRNL PMID 23375226 JRNL DOI 10.1016/J.BMCL.2013.01.008 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 17670 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.241 REMARK 3 R VALUE (WORKING SET) : 0.240 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 925 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3078 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 152 REMARK 3 SOLVENT ATOMS : 12 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.51000 REMARK 3 B22 (A**2) : -4.52000 REMARK 3 B33 (A**2) : 3.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.108 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.058 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.229 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.013 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4H95 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-OCT-12. REMARK 100 THE RCSB ID CODE IS RCSB075175. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-NOV-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17769 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 53.020 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.11500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.31 REMARK 200 R MERGE FOR SHELL (I) : 0.50700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1AOE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, KMES, GLYCINE, PH 6.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 59.24100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 59.42800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 59.24100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 59.42800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 83 99.06 -67.71 REMARK 500 LYS A 150 72.63 -112.81 REMARK 500 ASP B 87 -150.53 -144.22 REMARK 500 SER B 104 -144.65 -83.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 06U A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 06U B 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3QLS RELATED DB: PDB REMARK 900 RELATED ID: 3QLR RELATED DB: PDB REMARK 900 RELATED ID: 3QLW RELATED DB: PDB REMARK 900 RELATED ID: 4H96 RELATED DB: PDB REMARK 900 RELATED ID: 4H97 RELATED DB: PDB REMARK 900 RELATED ID: 4H98 RELATED DB: PDB DBREF 4H95 A 4 192 UNP Q5A5E0 Q5A5E0_CANAL 4 192 DBREF 4H95 B 4 192 UNP Q5A5E0 Q5A5E0_CANAL 4 192 SEQRES 1 A 189 PRO ASN VAL ALA ILE ILE VAL ALA ALA LEU LYS PRO ALA SEQRES 2 A 189 LEU GLY ILE GLY TYR LYS GLY LYS MET PRO TRP ARG LEU SEQRES 3 A 189 ARG LYS GLU ILE ARG TYR PHE LYS ASP VAL THR THR ARG SEQRES 4 A 189 THR THR LYS PRO ASN THR ARG ASN ALA VAL ILE MET GLY SEQRES 5 A 189 ARG LYS THR TRP GLU SER ILE PRO GLN LYS PHE ARG PRO SEQRES 6 A 189 LEU PRO ASP ARG LEU ASN ILE ILE LEU SER ARG SER TYR SEQRES 7 A 189 GLU ASN GLU ILE ILE ASP ASP ASN ILE ILE HIS ALA SER SEQRES 8 A 189 SER ILE GLU SER SER LEU ASN LEU VAL SER ASP VAL GLU SEQRES 9 A 189 ARG VAL PHE ILE ILE GLY GLY ALA GLU ILE TYR ASN GLU SEQRES 10 A 189 LEU ILE ASN ASN SER LEU VAL SER HIS LEU LEU ILE THR SEQRES 11 A 189 GLU ILE GLU HIS PRO SER PRO GLU SER ILE GLU MET ASP SEQRES 12 A 189 THR PHE LEU LYS PHE PRO LEU GLU SER TRP THR LYS GLN SEQRES 13 A 189 PRO LYS SER GLU LEU GLN LYS PHE VAL GLY ASP THR VAL SEQRES 14 A 189 LEU GLU ASP ASP ILE LYS GLU GLY ASP PHE THR TYR ASN SEQRES 15 A 189 TYR THR LEU TRP THR ARG LYS SEQRES 1 B 189 PRO ASN VAL ALA ILE ILE VAL ALA ALA LEU LYS PRO ALA SEQRES 2 B 189 LEU GLY ILE GLY TYR LYS GLY LYS MET PRO TRP ARG LEU SEQRES 3 B 189 ARG LYS GLU ILE ARG TYR PHE LYS ASP VAL THR THR ARG SEQRES 4 B 189 THR THR LYS PRO ASN THR ARG ASN ALA VAL ILE MET GLY SEQRES 5 B 189 ARG LYS THR TRP GLU SER ILE PRO GLN LYS PHE ARG PRO SEQRES 6 B 189 LEU PRO ASP ARG LEU ASN ILE ILE LEU SER ARG SER TYR SEQRES 7 B 189 GLU ASN GLU ILE ILE ASP ASP ASN ILE ILE HIS ALA SER SEQRES 8 B 189 SER ILE GLU SER SER LEU ASN LEU VAL SER ASP VAL GLU SEQRES 9 B 189 ARG VAL PHE ILE ILE GLY GLY ALA GLU ILE TYR ASN GLU SEQRES 10 B 189 LEU ILE ASN ASN SER LEU VAL SER HIS LEU LEU ILE THR SEQRES 11 B 189 GLU ILE GLU HIS PRO SER PRO GLU SER ILE GLU MET ASP SEQRES 12 B 189 THR PHE LEU LYS PHE PRO LEU GLU SER TRP THR LYS GLN SEQRES 13 B 189 PRO LYS SER GLU LEU GLN LYS PHE VAL GLY ASP THR VAL SEQRES 14 B 189 LEU GLU ASP ASP ILE LYS GLU GLY ASP PHE THR TYR ASN SEQRES 15 B 189 TYR THR LEU TRP THR ARG LYS HET NDP A 201 48 HET 06U A 202 28 HET NDP B 201 48 HET 06U B 202 28 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM 06U 6-ETHYL-5-{(3R)-3-[3-METHOXY-5-(PYRIDIN-4-YL) HETNAM 2 06U PHENYL]BUT-1-YN-1-YL}PYRIMIDINE-2,4-DIAMINE FORMUL 3 NDP 2(C21 H30 N7 O17 P3) FORMUL 4 06U 2(C22 H23 N5 O) FORMUL 7 HOH *12(H2 O) HELIX 1 1 LEU A 29 ARG A 42 1 14 HELIX 2 2 ARG A 56 GLU A 60 1 5 HELIX 3 4 SER A 95 VAL A 103 1 9 HELIX 4 5 GLY A 114 ILE A 122 1 9 HELIX 5 6 SER A 139 ILE A 143 5 5 HELIX 6 7 PRO A 152 GLU A 154 5 3 HELIX 7 8 PRO A 160 GLY A 169 1 10 HELIX 8 9 LEU B 29 ARG B 42 1 14 HELIX 9 10 ARG B 56 GLU B 60 1 5 HELIX 10 11 SER B 95 ASN B 101 1 7 HELIX 11 12 GLY B 114 ILE B 122 1 9 HELIX 12 13 SER B 139 ILE B 143 5 5 HELIX 13 14 PRO B 152 GLU B 154 5 3 HELIX 14 15 PRO B 160 GLY B 169 1 10 SHEET 1 A 9 GLU A 84 ILE A 85 0 SHEET 2 A 9 ILE A 90 ALA A 93 -1 O HIS A 92 N GLU A 84 SHEET 3 A 9 LEU A 73 LEU A 77 1 N ILE A 76 O ILE A 91 SHEET 4 A 9 ARG A 49 GLY A 55 1 N VAL A 52 O LEU A 73 SHEET 5 A 9 VAL A 106 ILE A 111 1 O PHE A 110 N ILE A 53 SHEET 6 A 9 ASN A 5 LEU A 13 1 N ASN A 5 O VAL A 109 SHEET 7 A 9 VAL A 127 GLU A 136 1 O LEU A 131 N ILE A 8 SHEET 8 A 9 PHE A 182 ARG A 191 -1 O THR A 183 N GLU A 136 SHEET 9 A 9 TRP A 156 LYS A 158 -1 N THR A 157 O THR A 190 SHEET 1 B 9 GLU A 84 ILE A 85 0 SHEET 2 B 9 ILE A 90 ALA A 93 -1 O HIS A 92 N GLU A 84 SHEET 3 B 9 LEU A 73 LEU A 77 1 N ILE A 76 O ILE A 91 SHEET 4 B 9 ARG A 49 GLY A 55 1 N VAL A 52 O LEU A 73 SHEET 5 B 9 VAL A 106 ILE A 111 1 O PHE A 110 N ILE A 53 SHEET 6 B 9 ASN A 5 LEU A 13 1 N ASN A 5 O VAL A 109 SHEET 7 B 9 VAL A 127 GLU A 136 1 O LEU A 131 N ILE A 8 SHEET 8 B 9 PHE A 182 ARG A 191 -1 O THR A 183 N GLU A 136 SHEET 9 B 9 ILE A 177 GLU A 179 -1 N ILE A 177 O TYR A 184 SHEET 1 C 2 GLY A 18 GLY A 20 0 SHEET 2 C 2 THR A 147 PHE A 148 -1 O THR A 147 N ILE A 19 SHEET 1 D 9 GLU B 84 ILE B 85 0 SHEET 2 D 9 ILE B 90 ALA B 93 -1 O HIS B 92 N GLU B 84 SHEET 3 D 9 ARG B 72 LEU B 77 1 N ILE B 76 O ILE B 91 SHEET 4 D 9 ARG B 49 GLY B 55 1 N VAL B 52 O ILE B 75 SHEET 5 D 9 VAL B 106 ILE B 111 1 O PHE B 110 N ILE B 53 SHEET 6 D 9 ASN B 5 LEU B 13 1 N ASN B 5 O VAL B 109 SHEET 7 D 9 HIS B 129 GLU B 136 1 O THR B 133 N VAL B 10 SHEET 8 D 9 PHE B 182 ARG B 191 -1 O TRP B 189 N LEU B 130 SHEET 9 D 9 TRP B 156 GLN B 159 -1 N THR B 157 O THR B 190 SHEET 1 E 9 GLU B 84 ILE B 85 0 SHEET 2 E 9 ILE B 90 ALA B 93 -1 O HIS B 92 N GLU B 84 SHEET 3 E 9 ARG B 72 LEU B 77 1 N ILE B 76 O ILE B 91 SHEET 4 E 9 ARG B 49 GLY B 55 1 N VAL B 52 O ILE B 75 SHEET 5 E 9 VAL B 106 ILE B 111 1 O PHE B 110 N ILE B 53 SHEET 6 E 9 ASN B 5 LEU B 13 1 N ASN B 5 O VAL B 109 SHEET 7 E 9 HIS B 129 GLU B 136 1 O THR B 133 N VAL B 10 SHEET 8 E 9 PHE B 182 ARG B 191 -1 O TRP B 189 N LEU B 130 SHEET 9 E 9 ILE B 177 GLU B 179 -1 N GLU B 179 O PHE B 182 SHEET 1 F 2 GLY B 18 GLY B 20 0 SHEET 2 F 2 THR B 147 PHE B 148 -1 O THR B 147 N ILE B 19 CISPEP 1 LYS A 14 PRO A 15 0 -1.93 CISPEP 2 ARG A 67 PRO A 68 0 -2.55 CISPEP 3 GLY A 113 GLY A 114 0 -1.22 CISPEP 4 LYS B 14 PRO B 15 0 -2.08 CISPEP 5 ARG B 67 PRO B 68 0 0.31 CISPEP 6 GLY B 113 GLY B 114 0 1.19 SITE 1 AC1 24 VAL A 10 ALA A 11 ILE A 19 GLY A 23 SITE 2 AC1 24 LYS A 24 MET A 25 ARG A 30 GLY A 55 SITE 3 AC1 24 ARG A 56 LYS A 57 THR A 58 LEU A 77 SITE 4 AC1 24 SER A 78 ARG A 79 SER A 94 ILE A 112 SITE 5 AC1 24 GLY A 113 GLY A 114 ALA A 115 GLU A 116 SITE 6 AC1 24 ILE A 117 TYR A 118 GLU A 120 06U A 202 SITE 1 AC2 11 ILE A 9 VAL A 10 MET A 25 GLU A 32 SITE 2 AC2 11 ILE A 33 PHE A 36 SER A 61 PRO A 63 SITE 3 AC2 11 ILE A 112 TYR A 118 NDP A 201 SITE 1 AC3 23 VAL B 10 ALA B 11 ILE B 19 GLY B 23 SITE 2 AC3 23 LYS B 24 MET B 25 ARG B 30 GLY B 55 SITE 3 AC3 23 ARG B 56 LYS B 57 THR B 58 LEU B 77 SITE 4 AC3 23 SER B 78 ARG B 79 SER B 94 ILE B 112 SITE 5 AC3 23 GLY B 114 ALA B 115 GLU B 116 ILE B 117 SITE 6 AC3 23 TYR B 118 06U B 202 HOH B 308 SITE 1 AC4 10 ILE B 9 VAL B 10 ALA B 11 GLU B 32 SITE 2 AC4 10 PHE B 36 PHE B 66 LEU B 69 ILE B 112 SITE 3 AC4 10 TYR B 118 NDP B 201 CRYST1 118.482 118.856 39.284 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008440 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008414 0.000000 0.00000 SCALE3 0.000000 0.000000 0.025456 0.00000 MASTER 248 0 4 14 40 0 18 6 0 0 0 30 END